与SIN3A结合THOC1复合体,以调节R环并促进质母细胞瘤的进展
Shreya Budhiraja1, Umme H Faisal2, Shivani Baisiwala2
1Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, USA; Northwestern Medicine Malnati Brain Tumor Institute of the Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, USA.
向THO复合体1 (THOC1) 是针对质母细胞瘤 (GBM) 的一个有希望的策略. 降低THOC1会破坏R循环,阻碍GBM细胞的复制,并改善模型中的生存率.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 质母细胞瘤 (GBM) 是一种具有不良预后的侵袭性脑瘤.
- 确定新的治疗点对于改善GBM患者的生存率至关重要.
研究的目的:
- 使用CRISPR淘汰屏幕识别质母细胞瘤发病的关键驱动因素.
- 调查THO复合体1 (THOC1) 在GBM发育和进展中的作用.
主要方法:
- 在患者衍生异种移植 (PDX) 模型中使用CRISPR淘汰查.
- 细胞活力,存活率和瘤移植的评估.
- RNA测序和分析R环水平和基因素脱乙烯化.
主要成果:
- 确定THO复合物1 (THOC1) 是GBM的一个关键驱动因素.
- 在PDX模型中,THOC1的抑制降低了GBM细胞活力,提高了PDX模型中的存活率.
- 降低THOC1导致R循环水平增加,基因素脱乙烯化减少和端粒缩短,特别是在端粒.
结论:
- THOC1在维护R环景观方面发挥着至关重要的作用,这对于GBM细胞复制至关重要.
- 准THOC1是一种潜在的治疗策略,可以破坏GBM的复制潜力并改善结果.
更多相关视频
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
07:18Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
Published on: June 13, 2019
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Hedgehog Signaling Pathway
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
lncRNA - Long Non-coding RNAs
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
